Quantcast
Home > Quotes > NVIV

InVivo Therapeutics Holdings Corp Common Stock (NVIV) Quote & Summary Data

NVIV 
$8.59
*  
0.34
4.12%
Get NVIV Alerts
*Delayed - data as of Apr. 20, 2018  -  Find a broker to begin trading NVIV now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    NVIV After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 7.72 / $ 8.75
Today's High / Low
$ 8.75 / $ 8.21
Share Volume
9,138
50 Day Avg. Daily Volume
28,837
Previous Close
$ 8.25
52 Week High / Low
$ 106.25 / $ 7.71
Market Cap
523,011
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Special Dividend Data

Special Dividend
N/A
Special Dividend Date
Apr. 17, 2018
Special Dividend Payment Date
N/A

Intraday Chart

Shares Traded

Share Volume:
9,138
50 Day Avg. Daily Volume:
28,837

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -20.25

Trading Range

The current last sale of $8.59 is 11.41% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 8.75 $ 106.25
 Low: $ 8.21 $ 7.71

Company Description (as filed with the SEC)

We are a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries, or SCIs. Our mission is to redefine the life of the SCI patient, and we seek to develop treatment options intended to provide meaningful improvement in patient outcomes following SCI. Our approach to treating acute SCIs is based on our investigational Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord and is intended to treat acute SCI. The Neuro-Spinal Scaffold implant incorporates intellectual property licensed under an exclusive, worldwide license from Boston Children's Hospital and the Massachusetts Institute of Technology.  ... More ...  

Risk Grade

Where does NVIV fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 8.24
Open Date:
Apr. 20, 2018
Close Price:
$ 8.51
Close Date:
Apr. 20, 2018

Consensus Recommendation

Analyst Info